XKXue Kong

Xue Kong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xue Kong has a total of 93 co-authors. Here are the top co-authors by number of shared publications:

  • Guanzhao Liang

    Department of Medical Mycology, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College

    9 shared publications
  • Weida Liu

    Department of Medical Mycology, Institute of Dermatology, Chinese Academy of Medical Science and Peking Union Medical College, Nanjing, China

    7 shared publications
  • Xiaofang Li

    Department of Medical Mycology, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College

    6 shared publications
  • Wenting Xie

    Department of Medical Mycology, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College

    5 shared publications
  • Xiaodong She

    Department of Medical Mycology Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Science & Peking Union Medical College Nanjing China

    5 shared publications
  • Huan Mei

    Department of Medical Mycology, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College

    4 shared publications

Latest Publications

  • Open Access

    In vitro susceptibility and provisional epidemiological cutoff values for eight antifungal agents against Trichophyton mentagrophytes and Trichophyton interdigitale : a multicenter study from China

    by Hailin Zheng, Wenting Xie, Yinggai Song, Cunwei Cao, Meng Fu, Biling Dong, Xiaodong Wang, Xue Kong, Naicen Ge, Huan Mei, et al.

    Dermatophytosis is a highly prevalent superficial fungal infection, yet antifungal susceptibility testing results remain difficult to interpret because clinical breakpoints are unavailable, and epidemiological cutoff values (ECVs) are still limited for most dermatophyte–drug combinations. We conducted a multicenter study of 305 Trichophyton mentagrophytes and Trichophyton interdigitale isolates collected between 2019 and 2024 at six tertiary hospitals across geographically diverse regions of China. Antifungal susceptibility testing was performed using the CLSI M38 broth microdilution method under standardized quality control, and provisional ECVs were derived following CLSI M57 guidance. For T. mentagrophytes , fluconazole showed a non-unimodal MIC distribution and was not assigned a provisional ECV. The remaining seven agents yielded ECVs of 1 µg/mL for ciclopirox olamine and griseofulvin, 0.5 µg/mL for itraconazole, 0.06 µg/mL for voriconazole, 0.25 µg/mL for posaconazole and amorolfine, and 0.016 µg/mL for terbinafine. For T. interdigitale , fluconazole showed a complex non-unimodal distribution, whereas itraconazole and posaconazole showed unstable low-MIC shoulders precluding ECV estimation. The remaining five agents yielded ECVs of 1 µg/mL for ciclopirox olamine, 0.25 µg/mL for griseofulvin, 0.12 µg/mL for voriconazole and amorolfine, and 0.016 µg/mL for terbinafine. Isolates above the provisional ECVs were uncommon for most combinations (≤2.5%), except for griseofulvin against T. interdigitale (20.5%). Overall, the two species showed distinct MIC distribution profiles, underscoring the value of species-level analysis and continued surveillance. These multicenter CLSI-based data and provisional ECVs provide a contemporary baseline for species-specific interpretation of dermatophyte susceptibility data in China. IMPORTANCE: Reliable interpretation of dermatophyte antifungal susceptibility testing remains limited because clinical breakpoints and epidemiological cutoff values (ECVs) are unavailable for most dermatophyte–drug combinations. This is particularly important for the Trichophyton mentagrophytes / Trichophyton interdigitale species complex, which is increasingly implicated in refractory dermatophytosis and may display species-specific susceptibility patterns. In this multicenter study, we established provisional epidemiological cutoff values for most tested species–agent combinations and showed that these two closely related species differ in MIC distribution profiles and in the detection of non-wild-type isolates. These data provide practical laboratory thresholds for recognizing isolates with reduced susceptibility, highlight the limitations of complex-level interpretation, establish a contemporary baseline for dermatophyte susceptibility surveillance in China, and may help support laboratory-informed antifungal decision-making.

  • Open Access

    The First Isolation of Multiple Antifungal‐Drug‐Resistant Trichophyton Rubrum in China and the Novel Resistance Mechanism

    by Ge Song, Wenting Xie, Xue Kong, Hailin Zheng, Clement K M Tsui, Weida Liu, Xiaofang Li, Guanzhao Liang

    Objectives: This study reports the first isolation of a multidrug‐resistant Trichophyton rubrum strain in China, characterizing its drug resistance profile and mechanisms. Methods: The isolate was identified by internal transcribed spacer (ITS) sequencing and phylogenetic analysis. In vitro antifungal susceptibility testing (AFST) was performed according to the M38‐A3 CLSI guideline to determine minimum inhibitory concentrations (MICs) against eight antifungals (terbinafine, itraconazole, fluconazole, amorolfine, griseofulvin, voriconazole, luliconazole and amphotericin B). Whole genome sequencing (WGS), transcriptome sequencing and qRT‐PCR were performed to explore the resistance mechanism. Results: The multidrug‐resistant T. rubrum strain L‐6424 was isolated from a Chinese patient with generalised tinea corporis/cruris, tinea unguium and tinea manuum. It exhibited elevated MICs to terbinafine (2 mg/L), itraconazole (0.5 mg/L), and amorolfine (0.5 mg/L). The phylogenetic tree based on genome‐wide single nucleotide polymorphisms (SNPs) showed L‐6424 is not a novel genotype of T. rubrum , with high genetic similarity (99.94%) with the reference strain (CBS 139224). There were three amino acid substitutions in the squalene epoxidase (SQLE), including the previously reported F397L and H440Y, as well as a newly discovered V105M, and one amino acid substitution in the CYP51A (R239C) was identified. Also, significant differences at the transcriptome level between the drug‐resistant and sensitive strains were observed, and it was screened and found that CYP51A, TruMDR5 and TERG_08139 may be related to azole resistance. Conclusions: Drug‐resistant T. rubrum has emerged in China, indicating the possibly increasing severity of antifungal resistance. The complex mechanism of multidrug‐resistant dermophytes poses challenges to clinical treatment, needing more attention.


  • Open Access

    In vitro susceptibility profiles of 16 antifungal drugs against Trichophyton indotineae

    by Wenting Xie, Xue Kong, Hailin Zheng, Huan Mei, Naicen Ge, Weida Liu, Guanzhao Liang, Xiaofang Li

    The worldwide emergence of Trichophyton indotineae has garnered significant attention due to its growing resistance to conventional antifungal therapies, posing significant challenges to the effective management of dermatophytosis. The in vitro activities of 16 antifungals were tested against 37 T. indotineae isolates using the broth microdilution method according to Clinical and Laboratory Standards Institute protocol M38-A3. Luliconazole and amorolfine exhibited low MICs, while itraconazole showed moderately decreased susceptibility, making them preferred treatment options. Echinocandins demonstrated favourable in vitro activity against T. indotineae , but their potential as therapeutic alternatives for recalcitrant dermatophytosis remains uncertain due to pharmacokinetic and pharmacodynamic limitations. In contrast, terbinafine, fluconazole, griseofulvin, oteseconazole, isavuconazole, ravuconazole, and amphotericin B exhibited elevated MICs for many strains, with strong correlations between certain azoles, indicating potential cross-resistance. A difference in the susceptibility to terbinafine and voriconazole between Chinese and Indian isolates was observed. These findings could provide valuable insights into antifungal resistance patterns and help guide treatment strategies for T. indotineae infections. IMPORTANCE: Trichophyton indotineae is a novel emerging dermatophyte that has rapidly spread globally in recent years. Its resistance to first-line antifungal agents, particularly terbinafine and fluconazole, has significantly limited treatment options, emphasizing the urgent need for alternative therapies. This study provides comprehensive antifungal susceptibility data for 16 available antifungal agents, offering valuable insights into potential treatment strategies.


  • Antifungal resistance of the Trichophyton mentagrophytes/Trichophyton interdigitale species complex: Insights from the China Antifungal Resistance Dermatophytes Surveillance network Study (CARDS)

    by Xue Kong, Wenting Xie, Meng Fu, Peiying Feng, Zhihua Li, Hongfang Liu, Zhongsheng Tong, Palidae Abliz, Yanping Jiang, Lianjuan Yang, et al.

    Background: Dermatophytosis caused by the Trichophyton mentagrophytes/T. interdigitale species complex (TMTISC) has attracted global attention, with increasing reports of terbinafine‐resistant T. indotineae in China. Objectives: This study aims to evaluate the epidemiological features of antifungal‐resistant TMTISC in China and monitor the prevalence of T. indotineae . Methods: A total of 230 TMTISC strains were isolated from nine tertiary hospitals across three economic regions of China. These isolates were identified through molecular sequencing and phylogenetic analysis. Additionally, in vitro antifungal susceptibility testing (AFST) was performed for eight drugs, following the EUCAST 11.0 protocol. Mutations in the squalene epoxidase ( SQLE ) gene were detected. Results: The phylogenetic tree revealed that 120 strains (52.17%) were T. mentagrophytes , 92 (40.0%) were T. interdigitale , and 18 (7.83%) were T. indotineae . Eight different genotypes were identified, including TM‐IX, which was predominant in China, along with two newly discovered genotypes, TM‐XXX and TM‐XXXI. Among T. mentagrophytes isolates, tinea faciei (44.17%) was the common clinical type, primarily isolated from the central region. T. interdigitale isolates were mainly found in onychomycosis (36.96%), T. indotineae was commonly isolated from tinea corporis (94.44%) and tinea cruris (55.56%). AFST showed that all isolates of T. interdigitale and T. mentagrophytes were susceptible to terbinafine [minimum inhibitory concentrations (MICs) < 0.125 mg/L] and voriconazole (MICs < 0.5 mg/L). All isolates of T. indotineae were resistant to terbinafine (0.25 to >4.0 mg/L), exhibiting a single amino acid substitution in SQLE (Phe397Leu, Leu393Ser or Phe415Cys). Additionally, elevated MICs were observed in TMTISC for itraconazole, miconazole, ciclopirox (1–2 mg/L) and griseofulvin (1–64 mg/L). Conclusions: The TMTISC was predominantly composed of T. mentagrophytes , followed by T. interdigitale and T. indotineae . A rising trend of reduced azoles susceptibility in TMTISC and multi‐drug resistance among T. indotineae isolates has been observed in China.


  • Open Access

    Genomic epidemiology and antifungal resistance of emerging Trichophyton indotineae in China

    by Wenting Xie, Guanzhao Liang, Xue Kong, Clement K. M. Tsui, Xiaodong She, Weida Liu, Xiaofang Li

    S:The emergence and spread of antifungal-resistant Trichophyton indotineae pose an increasing public health concern worldwide. Multidrug-resistant T. indotineae infections have been reported in China in the past few years. To understand the genetic relationship and the origin of these Chinese isolates, as well as their relationship to the global collections, we sequenced the whole genomes of 31 isolates using the Illumina platforms. Genomic epidemiology was performed on a dataset of 181 T. indotineae isolates from China and 8 other countries, representing the largest genome-wide analysis. Single nucleotide polymorphism analysis revealed that T. indotineae can be divided into four distinct phylogenetic groups (I, II, III, IV), with regional clonal transmission clusters identified in eastern China; T. indotineae was introduced into China more than once given the genetic variability. The isolates from South Asia may be the source of Chinese isolates based on epidemiological information. There were differences in the prevalence and resistance profiles among four phylogenetic groups, with Group III being predominant and exhibiting a higher terbinafine resistance rate of 88.24% and azole resistance. Also, we characterised the role of gene mutation, copy number variation, and gene expression in antifungal drug resistance. Terbinafine resistance could be mainly associated with Phe397Leu substitution in SQLE, and azole resistance might be related to increased copy number of CYP51B, as well as elevated MDR2 and MDR3 expression. Given the clinical challenges posed by T. indotineae, this emerging dermatophyte should be recognised as a global threat, necessitating urgent collaborative surveillance and management strategies.


  • Chinese expert consensus on management of antifungal‐resistant dermatophytoses (2024 edition)

    by Guanzhao Liang, Xiaofang Li, Ruoyu Li, Hai Wen, Jun Gu, Yuping Ran, Liyan Xi, Fuqiu Li, Qiangqiang Zhang, Cunwei Cao, et al.

    Antifungal‐resistant dermatophytes (ARD) infection is a hotspot issue in clinical microbiology and the dermatology field. Trichophyton indotineae as the dominant species of dermatophyte with terbinafine‐resistance or multidrug resistance, is easy to be missed detection clinically, which brings severe challenges to diagnosis and treatment. ARD infection cases have emerged in China, and it predicts a risk of transmission among human. Based on the existing medical evidence and research data, the Mycology Group of Combination of Traditional and Western Medicine Dermatology and Chinese Antifungal⁃Resistant Dermatophytoses Expert Consensus Group organized experts to make consensus on the management of the infection. Here, the consensus formulated diagnosis and treatment recommendations, to raise attention to dermatophytes drug resistance problem, and expect to provide reference information for the clinical diagnosis, treatment, prevention and control.


  • Rapid emergence of recalcitrant dermatophytosis caused by a cluster of multidrug-resistant Trichophyton indotineae in China

    by Wenting Xie, Xue Kong, Hailin Zheng, Huan Mei, Naicen Ge, Suquan Hu, Qiong Wang, Yuying Huang, Xiaodong She, Weida Liu, et al.

    We describe 14 cases of native refractory dermatophytes caused by Trichophyton indotineae diagnosed at a hospital in China since 2021, primarily diagnosed in the past 1 year and from the same province. Trichophyton indotineae isolates were resistant to multiple antifungals and harboured Phe397Leu or Leu393Ser substitutions in the squalene epoxidase enzyme. Short-term rapid emergence of multidrug-resistant T. indotineae in China poses increasing threats to public safety and warrants continued public health surveillance.


  • Prior selection of itraconazole in the treatment of recalcitrant Trichophyton indotineae infection: Real‐world results from retrospective analysis

    by Ge Song, Xue Kong, Xiaofang Li, Weida Liu, Guanzhao Liang

    Background: The number of terbinafine‐resistant Trichophyton indotineae is increasing in recent years while the treatment is still a matter to discuss.Objectives: To explore the best therapeutic approach, we present real‐world treatment of T. indotineae infection by analysing publicly available data.Methods: We have reviewed all published articles, mainly including case reports and case series, on the drug‐resistant T. mentagrophytes complex by using the key search terms to search the databases.Results: We enrolled 25 articles from 14 countries, including 203 times of treatment information for 113 patients. The cure rate of itraconazole 200 mg per day at the fourth, eighth and the twelfth week were 27.27%, 48.48% and 54.55%, respectively, which was significantly higher than terbinafine 250 mg per day (8.77%, 24.56% and 28.07%) and even 500 mg/d terbinafine. Griseofulvin 500–1000 mg for 2–6 months may be effective while fluconazole had no record of successful treatment. Voriconazole and ravuconazole had potential therapeutic efficacy. Topical therapy alone showed limited therapeutic efficacy, but the combination with oral antifungals can be alternative.Conclusion: Oral itraconazole 200 mg per day for 4–8 weeks was the most effective treatment out of these commonly used antifungal drugs, and can be prior selection.


  • Open Access

    Antifungal Susceptibility and Mutations in the Squalene Epoxidase Gene in Dermatophytes of the Trichophyton mentagrophytes Species Complex

    by Xue Kong, Chao Tang, Ashutosh Singh, Sarah A. Ahmed, Abdullah M. S. Al-Hatmi, Anuradha Chowdhary, Pietro Nenoff, Yvonne Gräser, Steven Hainsworth, Ping Zhan, et al.

    During the past decade, a prolonged and serious outbreak of dermatophytosis due to a terbinafine-resistant novel species in the Trichophyton mentagrophytes - T. interdigitale complex has been ongoing in India, and it has spread to several European countries. The objective of this study was to investigate the molecular background of the squalene epoxidase ( SQLE ) gene in order to understand the risk of emergence and spread of multiresistance in dermatophytes.